Brief: Pharmaust Says Successfully Completed A Pre-Ind Meeting With FDA

Neurizon Therapeutics

16/02/2024 01:31

Feb 16 (Reuters) - Pharmaust Ltd  PAA.AX :
    * SUCCESSFULLY COMPLETED A PRE-IND MEETING WITH FDA
    * FDA GAVE POSITIVE FEEDBACK AND OUTLINED PATH REQUIRED TO
POTENTIALLY RECEIVE ACCELERATED AND FULL APPROVAL OF MONEPANTEL

Source text for Eikon:  ID:nASX26GPtL 
Further company coverage:  PAA.AX 

 ((Reuters.Briefs@thomsonreuters.com;))